Loading...
•
Jun 30, 2024
Health Catalyst Q2 2024 Earnings Report
Health Catalyst's Q2 2024 financial results were reported, demonstrating strong performance with revenue and Adjusted EBITDA exceeding guidance.
Key Takeaways
Health Catalyst reported strong Q2 2024 financial results, with total revenue of $75.9 million and Adjusted EBITDA of $7.5 million, both exceeding the midpoint of the company's quarterly guidance. The company also saw strong bookings performance, signing more net new Platform Subscription Clients in the first half of 2024 than in all of 2023.
Total revenue reached $75.9 million, a 4% increase year-over-year.
Adjusted EBITDA was $7.5 million, a 114% increase year-over-year.
Net loss improved by 59% year-over-year, coming in at $(13.5) million.
Signed more net new Platform Subscription Clients in the first half of 2024 than in all of 2023.
Revenue by Segment
Forward Guidance
Health Catalyst provides forward-looking guidance on total revenue and Adjusted EBITDA for Q3 2024 and the full year 2024.
Positive Outlook
- Q3 2024 total revenue is expected to be between $74.5 million and $77.5 million.
- Q3 2024 Adjusted EBITDA is expected to be between $6.0 million and $8.0 million.
- Full year 2024 total revenue is expected to be between $304.0 million and $312.0 million.
- Full year 2024 Adjusted EBITDA is expected to be between $24.0 million and $26.0 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...